List of Tables
Table 1. Global Novel T Cell Immunotherapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Activated T-cells
Table 3. Key Players of Virus Driven T-cells
Table 4. Key Players of Tregs
Table 5. Key Players of T-cell Vaccines
Table 6. Key Players of Others
Table 7. Global Novel T Cell Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Novel T Cell Immunotherapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Novel T Cell Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Novel T Cell Immunotherapies Market Share by Region (2020-2025)
Table 11. Global Novel T Cell Immunotherapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Novel T Cell Immunotherapies Market Share by Region (2026-2031)
Table 13. Novel T Cell Immunotherapies Market Trends
Table 14. Novel T Cell Immunotherapies Market Drivers
Table 15. Novel T Cell Immunotherapies Market Challenges
Table 16. Novel T Cell Immunotherapies Market Restraints
Table 17. Global Novel T Cell Immunotherapies Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Novel T Cell Immunotherapies Market Share by Players (2020-2025)
Table 19. Global Top Novel T Cell Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel T Cell Immunotherapies as of 2024)
Table 20. Ranking of Global Top Novel T Cell Immunotherapies Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Novel T Cell Immunotherapies Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Novel T Cell Immunotherapies, Headquarters and Area Served
Table 23. Global Key Players of Novel T Cell Immunotherapies, Product and Application
Table 24. Global Key Players of Novel T Cell Immunotherapies, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Novel T Cell Immunotherapies Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Novel T Cell Immunotherapies Revenue Market Share by Type (2020-2025)
Table 28. Global Novel T Cell Immunotherapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Novel T Cell Immunotherapies Revenue Market Share by Type (2026-2031)
Table 30. Global Novel T Cell Immunotherapies Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Novel T Cell Immunotherapies Revenue Market Share by Application (2020-2025)
Table 32. Global Novel T Cell Immunotherapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Novel T Cell Immunotherapies Revenue Market Share by Application (2026-2031)
Table 34. North America Novel T Cell Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Novel T Cell Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Novel T Cell Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Novel T Cell Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Novel T Cell Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Novel T Cell Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Novel T Cell Immunotherapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Novel T Cell Immunotherapies Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Novel T Cell Immunotherapies Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Novel T Cell Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Novel T Cell Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Novel T Cell Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Novel T Cell Immunotherapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Novel T Cell Immunotherapies Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Novel T Cell Immunotherapies Market Size by Country (2026-2031) & (US$ Million)
Table 49. Atara Biotherapeutics Company Details
Table 50. Atara Biotherapeutics Business Overview
Table 51. Atara Biotherapeutics Novel T Cell Immunotherapies Product
Table 52. Atara Biotherapeutics Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 53. Atara Biotherapeutics Recent Development
Table 54. Allovir Company Details
Table 55. Allovir Business Overview
Table 56. Allovir Novel T Cell Immunotherapies Product
Table 57. Allovir Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 58. Allovir Recent Development
Table 59. Eureka Therapeutics Company Details
Table 60. Eureka Therapeutics Business Overview
Table 61. Eureka Therapeutics Novel T Cell Immunotherapies Product
Table 62. Eureka Therapeutics Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 63. Eureka Therapeutics Recent Development
Table 64. Eutilex Company Details
Table 65. Eutilex Business Overview
Table 66. Eutilex Novel T Cell Immunotherapies Product
Table 67. Eutilex Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 68. Eutilex Recent Development
Table 69. Gammadelta Therapeutics Company Details
Table 70. Gammadelta Therapeutics Business Overview
Table 71. Gammadelta Therapeutics Novel T Cell Immunotherapies Product
Table 72. Gammadelta Therapeutics Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 73. Gammadelta Therapeutics Recent Development
Table 74. Neximmune Company Details
Table 75. Neximmune Business Overview
Table 76. Neximmune Novel T Cell Immunotherapies Product
Table 77. Neximmune Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 78. Neximmune Recent Development
Table 79. Ose Immunotherapeutics Company Details
Table 80. Ose Immunotherapeutics Business Overview
Table 81. Ose Immunotherapeutics Novel T Cell Immunotherapies Product
Table 82. Ose Immunotherapeutics Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 83. Ose Immunotherapeutics Recent Development
Table 84. Tevogen Bio Company Details
Table 85. Tevogen Bio Business Overview
Table 86. Tevogen Bio Novel T Cell Immunotherapies Product
Table 87. Tevogen Bio Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 88. Tevogen Bio Recent Development
Table 89. Windmil Therapeutics Company Details
Table 90. Windmil Therapeutics Business Overview
Table 91. Windmil Therapeutics Novel T Cell Immunotherapies Product
Table 92. Windmil Therapeutics Revenue in Novel T Cell Immunotherapies Business (2020-2025) & (US$ Million)
Table 93. Windmil Therapeutics Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Novel T Cell Immunotherapies Picture
Figure 2. Global Novel T Cell Immunotherapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Novel T Cell Immunotherapies Market Share by Type: 2024 VS 2031
Figure 4. Activated T-cells Features
Figure 5. Virus Driven T-cells Features
Figure 6. Tregs Features
Figure 7. T-cell Vaccines Features
Figure 8. Others Features
Figure 9. Global Novel T Cell Immunotherapies Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Novel T Cell Immunotherapies Market Share by Application: 2024 VS 2031
Figure 11. Lung Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Cytomegalovirus Infection Case Studies
Figure 14. Others Case Studies
Figure 15. Novel T Cell Immunotherapies Report Years Considered
Figure 16. Global Novel T Cell Immunotherapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Novel T Cell Immunotherapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Novel T Cell Immunotherapies Market Share by Region: 2024 VS 2031
Figure 19. Global Novel T Cell Immunotherapies Market Share by Players in 2024
Figure 20. Global Top Novel T Cell Immunotherapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel T Cell Immunotherapies as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Novel T Cell Immunotherapies Revenue in 2024
Figure 22. North America Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Novel T Cell Immunotherapies Market Share by Country (2020-2031)
Figure 24. United States Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Novel T Cell Immunotherapies Market Share by Country (2020-2031)
Figure 28. Germany Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Novel T Cell Immunotherapies Market Share by Region (2020-2031)
Figure 36. China Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Novel T Cell Immunotherapies Market Share by Country (2020-2031)
Figure 44. Mexico Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Novel T Cell Immunotherapies Market Share by Country (2020-2031)
Figure 48. Turkey Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Novel T Cell Immunotherapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Atara Biotherapeutics Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 52. Allovir Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 53. Eureka Therapeutics Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 54. Eutilex Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 55. Gammadelta Therapeutics Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 56. Neximmune Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 57. Ose Immunotherapeutics Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 58. Tevogen Bio Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 59. Windmil Therapeutics Revenue Growth Rate in Novel T Cell Immunotherapies Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
